Mindmed Benefits

Mindmed, a pharmaceutical company, develops psychedelic inspired medicines to treat mental health and addiction disorders. Its current pipeline includes LSD, psilocybin, MDMA (also known as Molly), and 18-MC.

The psychedelic-based drug maker announced plans to raise $30 million from a stock offering. This will increase the company’s cash stockpile and help fund its upcoming trials.

1. Mental Health

Psychedelic medicine drugs are currently being used to treat a range of mental health conditions including depression, PTSD, anxiety and cluster headaches. These treatments have shown a high rate of remission when administered with professional supervision and have also been shown to provide long-term, lasting benefits for patients.

Mindmed (NASDAQ: MNMD, NEO: MMED) is a clinical-stage biopharmaceutical company developing psychedelic-inspired therapies for the treatment of brain-based disorders. Its pipeline includes products based on the hallucinogenic substances psilocybin, LSD, MDMA and DMT.

The company recently announced that its IND application for MM-120, an LSD-based drug, has been approved by the FDA. A dose-optimization trial is scheduled to begin in early 2022. It will assess how much the drug reduces symptoms in patients suffering from generalized anxiety disorder and ADHD.

2. Pain Relief

Despite the fact that opioids are still a mainstay in pain treatment, there are new psychedelic compounds being tested for reducing chronic pain. According to MindMed, a startup pharmaceutical company, there are several studies underway to test LSD and other psychedelics on pain conditions such as fibromyalgia and phantom limb pain.

MindMed’s Chief Development Officer, Rob Barrow, believes that pain is one of the most overlooked areas for psychedelic drug research. He notes that early studies showed a single dose of LSD could reduce cancer pain for weeks and that a three-week course of the drug at low doses could help treat phantom limb pain.

3. Anxiety Relief

Anxiety is a common and debilitating condition that affects millions of people. Several drugs currently on the market, including selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), azapirones, and mixed antidepressants, can be used to treat anxiety.

An additional way to relieve anxiety is through diet. Diets that are high in zinc and magnesium have been shown to be effective for reducing anxiety symptoms.

The psychedelic drug LSD has also shown promise in the treatment of anxiety disorders. MindMed is conducting a phase 2b trial to test the effectiveness of MM-120, an optimized form of LSD for anxiety.

4. Detox

Detox benefits include boosting energy, cleansing the liver, aiding weight loss, reducing inflammation and promoting skin health. They can be a great way to improve your overall health, and they should be paired with healthy foods and exercise.

In addition, detox can also help with mental alertness and concentration. It helps the body to get rid of toxins that may be causing a lack of focus, fatigue and mood swings.

During a detox program, you’ll be under medical supervision with daily schedules that will reset your brain and help you set the stage for long-term recovery. You’ll also be surrounded by supportive professionals who will offer advice, support and encouragement throughout your detox.

5. Weight Loss

Psychedelic inspired medicines are designed to improve mental health and promote wellness, while alleviating suffering from a wide range of ailments. Many of these therapies involve taking a psychedelic drug, often in a controlled setting, such as a therapy clinic. The effects of these medications can be profound, including weight loss. MindMed’s product 18-MC, for example, has been shown to aid weight loss in obese patients with a history of obesity by stimulating fat breakdown and increasing metabolism. The company also hopes to develop a therapeutic platform that utilizes both experiential psychedelic-assisted therapy and non-hallucinogenic take-home medicines to treat a wide range of conditions.

With an extensive pipeline of psychedelic-inspired medicines and experiential therapies, MindMed is well-positioned to continue its progress as a leading global provider of medical cannabis. However, a variety of headwinds can challenge the company’s business sustainability.